Vincerx Pharma Inc reports results for the quarter ended in June - Earnings Summary

Vincerx Pharma

09/08/2023 13:01

* Vincerx Pharma Inc  VINC.OQ  reported a quarterly adjusted
loss
of 52 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 60 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Vincerx Pharma Inc's reported EPS for the quarter was a
loss
of 52 cents​.
    * The mean earnings estimate of analysts had fallen by
about 14.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Vincerx Pharma Inc shares had fallen by 31.5% this
quarter and
lost 12.6% so far this year.
    * The company reported a quarterly loss of $11.15 million.
    * Wall Street's median 12-month price target for Vincerx
Pharma
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 12:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.60          -0.52          Beat
 Mar. 31 2023      -0.52          -0.68          Missed
 Dec. 31 2022      -0.61          -0.65          Missed
 Sep. 30 2022      -0.55          -0.80          Missed